BMJ Open Diabetes Research & Care
is an open access diabetes journal from the ADA and BMJ that strives to publish innovative studies on diabetes in all disciplines and therapeutic areas as quickly and transparently as possible.
Impact Factor: 4.1
Citescore: 3.5
All metrics >>
Latest Articles
Epidemiology/Health services research:
Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis30 November 2023
Obesity studies:
Genetic variant rs9939609 in FTO is associated with body composition and obesity risk in Korean females23 November 2023
Genetics/Genomes/Proteomics/Metabolomics:
Unraveling shared risk factors for diabetic foot ulcer: a comprehensive Mendelian randomization analysis21 November 2023
Clinical care/Education/Nutrition:
Diagnostic accuracy of the 5.07 monofilament test for diabetes polyneuropathy: influence of age, sex, neuropathic pain and neuropathy severity21 November 2023
Psychosocial research:
Influence of depression on racial and ethnic disparities in diabetes control21 November 2023
Most Read Articles
Cardiovascular and metabolic risk:
How sweet is your love? Disentangling the role of marital status and quality on average glycemic levels among adults 50 years and older in the English Longitudinal Study of Ageing6 February 2023
Epidemiology/Health services research:
Prevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot–estimates from the Sri Lanka Health and Ageing Survey 2018/201915 February 2023
Emerging technologies, pharmacology and therapeutics:
Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, …15 November 2022
Cardiovascular and metabolic risk:
Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study22 May 2023
Epidemiology/Health services research:
Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada10 November 2022
Cardiovascular and Metabolic Risk
Cardiovascular and metabolic risk:
Uncovering heterogeneous cardiometabolic risk profiles in US adults: the role of social and behavioral determinants of health12 September 2023
Cardiovascular and metabolic risk:
MDRD is the eGFR equation most strongly associated with 4-year mortality among patients with diabetes in Colombia20 July 2023
Cardiovascular and metabolic risk:
Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial16 June 2023
Cardiovascular and metabolic risk:
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering13 June 2023
Altmetrics
